Gabapentin

Generic Name
Gabapentin
Brand Names
Gralise, Neurontin
Drug Type
Small Molecule
Chemical Formula
C9H17NO2
CAS Number
60142-96-3
Unique Ingredient Identifier
6CW7F3G59X
Background

Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...

Indication

In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...

Associated Conditions
Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
Associated Therapies
-

Effect of Gabapentin on Postoperative Opioid Analgesic Use and Pain in Adolescents Undergoing Tonsillectomy

First Posted Date
2021-08-27
Last Posted Date
2021-08-27
Lead Sponsor
Albany Medical College
Target Recruit Count
17
Registration Number
NCT05024825
Locations
🇺🇸

Albany Medical Center, Albany, New York, United States

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

First Posted Date
2021-06-25
Last Posted Date
2022-09-06
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT04939987
Locations
🇺🇸

Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2021-03-26
Last Posted Date
2022-08-11
Lead Sponsor
Mahidol University
Target Recruit Count
60
Registration Number
NCT04818450
Locations
🇹🇭

Ramathibodi Hospital, Mahidol University, Ratchathewi, Bangkok, Thailand

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2021-03-18
Last Posted Date
2021-09-17
Lead Sponsor
Pharma Guide CRO
Target Recruit Count
34
Registration Number
NCT04805827
Locations
🇪🇬

Pharma Guide, Cairo, Egypt

A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males

First Posted Date
2021-03-17
Last Posted Date
2022-05-20
Lead Sponsor
Dompé Farmaceutici S.p.A
Target Recruit Count
140
Registration Number
NCT04802967
Locations
🇬🇧

MAC Clinical Research Early Phase Unit, Manchester, United Kingdom

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2021-01-26
Last Posted Date
2024-11-04
Lead Sponsor
University of California, Davis
Target Recruit Count
60
Registration Number
NCT04724252
Locations
🇺🇸

UC Davis Medical Center, Sacramento, California, United States

Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting

First Posted Date
2020-11-10
Last Posted Date
2021-05-27
Lead Sponsor
Ain Shams University
Target Recruit Count
150
Registration Number
NCT04622618
Locations
🇪🇬

AinShams University, Faculty of medicine, Cairo, Egypt

Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial)

First Posted Date
2020-11-06
Last Posted Date
2024-05-08
Lead Sponsor
University of British Columbia
Target Recruit Count
5
Registration Number
NCT04619862
Locations
🇨🇦

BC Children's Hospital, Vancouver, British Columbia, Canada

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

Early Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2020-11-03
Last Posted Date
2024-07-22
Lead Sponsor
Stanford University
Registration Number
NCT04613024
Locations
🇺🇲

Stanford University, Palo Alto, United States Minor Outlying Islands

The Efficacy of Postoperative Analgesia of Gabapentin Plus Nefopam in the Spinal Surgery

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2020-07-29
Last Posted Date
2021-06-07
Lead Sponsor
Gia Dinh People Hospital
Target Recruit Count
60
Registration Number
NCT04491786
Locations
🇻🇳

Binh Huynh, Ho Chi Minh City, Ho Chi Minh, Vietnam

© Copyright 2024. All Rights Reserved by MedPath